AstraZeneca PLC (AZN) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Astrazeneca Plc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.094 -- 00:00:04.157 Good morning to those joining from the UK and the US. 00:00:04.157 -- 00:00:09.241 Good afternoon to those in Central Europe, and good evening to those listening in Asia. 00:00:09.241 -- 00:00:14.426 Welcome, ladies and gentlemen, to AstraZeneca's full year and Q4 2025 results conference 00:00:14.426 -- 00:00:18.169 call for investors and analysts. 00:00:18.169 -- 00:00:22.913 Before I hand over to AstraZeneca, I'd like to read the safe harbour statement. 00:00:22.913 -- 00:00:27.037 The company intends to utilise the safe harbour provisions of the United States Private 00:00:27.037 -- 00:00:31.239 Securities Litigation Reform Act of 1995. 00:00:31.300 -- 00:00:35.809 Participants on this call may make forward-looking statements with respect to the operations 00:00:35.809 -- 00:00:39.175 and financial performance of AstraZeneca. 00:00:39.175 -- 00:00:43.163 Although we believe our expectations are based on reasonable assumptions, by their very 00:00:43.163 -- 00:00:47.011 nature, forward-looking statements involve risks and uncertainties. 00:00:47.011 -- 00:00:51.277 and may be influenced by factors that could cause actual results to differ materially 00:00:51.277 -- 00:00:55.583 from those expressed or implied by these forward-looking statements. 00:00:55.583 -- 00:00:59.509 Any forward-looking statements made on this call reflect the knowledge and information 00:00:59.509 -- 00:01:02.513 available at the time of this call. 00:01:02.513 -- 00:01:07.340 The company undertakes no obligation to update forward-looking statements. 00:01:07.340 -- 00:01:11.526 Please also carefully review the forward-looking statements disclaimer in the slide deck 00:01:11.526 -- 00:01:16.124 that accompanies this meeting. For those joining remotely, th...